HOLOBIOME

FOUNDED | 2015

LEADERSHIP

Kim Lewis, Ph.D, Co-Founder, Director
Philip Strandwitz, Ph.D, Co-Founder, Director
Mike La Fleur, Ph.D, Co-Founder, Director, President

ABOUT HOLOBIOME

 

The human body is home to trillions of bacteria that affect our health in ways we do not yet entirely understand. However, recent research suggests that certain bacteria in the gut contributes to issues such as depression, visceral pain, and sleep disorders. Holobiome studies these neurotransmitter-modulating bacteria to determine a correlation between their presence in the body and how they affect health issues that were previously thought to be unrelated to bacteria. Using their findings, Holobiome provides vital information to the global health community, leading to the discovery of novel therapies for combating both mental and physiological health problems.